1. Sun, Yimin, Gao, Yong, Zhou, Yuxi, Wang, Dong, Tan, Li-Hai. 2021. IFNAR1 gene mutation may contribute to developmental stuttering in the Chinese population. In Hereditas, 158, 46. doi:10.1186/s41065-021-00211-y. https://pubmed.ncbi.nlm.nih.gov/34794508/
2. Liu, Zhihui, Chen, Zongxiang, Di, Jingya, Liu, Lanjun, Du, Fuliang. 2021. Efficient mutagenesis targeting the IFNAR1 gene in mice using a combination of Cas9 protein and dual gRNAs. In American journal of translational research, 13, 12094-12106. doi:. https://pubmed.ncbi.nlm.nih.gov/34786147/
3. Guerrero-Rodríguez, J, Cárdenas-Vargas, A, Gutierrez-Silerio, G, Armendáriz-Borunda, J, Salazar-Montes, A. 2021. Delivery of Anti-IFNAR1 shRNA to Hepatic Cells Decreases IFNAR1 Gene Expression and Improves Adenoviral Transduction and Transgene Expression. In Molecular biotechnology, 64, 413-423. doi:10.1007/s12033-021-00408-6. https://pubmed.ncbi.nlm.nih.gov/34687024/
4. Baker, Tina, Sharifian, Hoda, Newcombe, Paul J, Brohawn, Philip Z, Csomor, Eszter. 2024. Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials. In Annals of the rheumatic diseases, 83, 1018-1027. doi:10.1136/ard-2023-225445. https://pubmed.ncbi.nlm.nih.gov/38569851/
5. Marks, Zoe R C, Campbell, Nicole K, Mangan, Niamh E, Bourke, Nollaig M, Hertzog, Paul J. 2023. Interferon-ε is a tumour suppressor and restricts ovarian cancer. In Nature, 620, 1063-1070. doi:10.1038/s41586-023-06421-w. https://pubmed.ncbi.nlm.nih.gov/37587335/